Safety Study of Inhaled Carbon Monoxide to Treat Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)

Conditions:   Acute Respiratory Distress Syndrome;   Sepsis Interventions:   Drug: Inhaled Carbon Monoxide at CFK equation-determined personalized dose (200-500 ppm to achieve a COHb level of 6-8%);   Other: Inhaled Medical air Sponsors:   Brigham and Women's Hospital;   Weill Medical College of Cornell University;   Massachusetts General Hospital;   Duke University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials